Detail

vapitadine dihydrochloride

Description

Name: vapitadine dihydrochloride
Type: small molecule
Groups: investigational
Indication: Investigated for use/treatment in atopic dermatitis.
Accession Number: DB05738 ( DB05738)
Description: Vapitadine dihydrochloride is an antihistamine that Barrier Therapeutics is developing as a treatment for allergic reactions of the skin, such as those associated with hives and for the itch associated with atopic dermatitis. An advantage of vapitadine dihydrochloride over other antihistamines may be the absence of the sedation, even at high doses.
Structure:
Prescription Products: Not Available
Generic Prescription Products: Not Available
Over the Counter Products: Not Available
International Brands
  • No Brands

Brand Names
  • No Brands

Brand Mixtures
Brand NameIngredients

Categories
  • No Category

Pharmacology

Indication: Investigated for use/treatment in atopic dermatitis.
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half life: Not Available
Clearance: Not Available
Toxicity: Not Available
Affected organisms
  • Not Available

SNP Mediated Adverse Drug Reactions
  • Not Available

Pharmacoeconomics

Manufacturers:
  • Not Available

Packagers:
  • Not Available

Dosage forms
FormRouteStrength

Prices
Unit descriptionCostUnit

Patents
CountryPatent NumberApprovedExpires (estimated)

Interactions

Drug Interactions
DrugInteraction

Food Interactions:
  • Not Available

Taxonomy

Kingdom: Organic compounds
Super Class: Not Available
Class: Not Available
Sub Class: Not Available
Direct Parent: Not Available
Alternative Parents:
  • Aralkylamines
  • Azacyclic compounds
  • Azepines
  • Benzenoids
  • Carbonyl compounds
  • Dialkylamines
  • Heteroaromatic compounds
  • Hydrocarbon derivatives
  • Hydrochlorides
  • N-substituted imidazoles
  • Piperidines
  • Primary carboxylic acid amides

substituent:
  • Amine
  • Aralkylamine
  • Aromatic heteropolycyclic compound
  • Azacycle
  • Azepine
  • Azole
  • Benzazepine
  • Benzenoid
  • Carbonyl group
  • Carboxamide group
  • Carboxylic acid derivative
  • Heteroaromatic compound
  • Hydrocarbon derivative
  • Hydrochloride
  • Imidazole
  • N-substituted imidazole
  • Organonitrogen compound
  • Organooxygen compound
  • Piperidine
  • Primary carboxylic acid amide
  • Secondary aliphatic amine
  • Secondary amine

References

Synthesis Reference: Not Available
General Reference: Not Available
External Links:
ResourceLink

ATC Codes:
  • Not Available

AHFS Codes:
  • Not Available

MSDS: Download
SiteLock

© Copyright 2022 The Purple Society, Purple Gladiator, Trialsmap, The Purple Drug Guide, and One Person CAN Make A Difference! are all registered trademarks of The Purple Society. The Purple Society, a not-for-profit, section 501(c)(3) #273785281.

The Purple Society website is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through this site should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider.

CONTACT US

The Purple Society team is here for you 24 hours a day, 7 days a week. Send us an email and we'll get right back to you.

Sending
or

Log in with your credentials

Forgot your details?